Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

NCT02594189 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

NIH

Sponsor class

Conditions

Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2

Interventions

OTHER: Live recombinantly derived A/Bethesda/MM1/H3N2 virus

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)